 I think translating that, though, into action in terms of how to bring new therapies forward is where we're somewhat stalled at this point. And that's the connection that we hope to make using these new measures or new endpoints. Is that the most significant thing that you believe will lead to improvement, or are there other ways that this process could be improved for more transplant patients?